Immune mechanisms in angiotensin II-induced target-organ damage

Annals of Medicine

Volumn 44, Issue SUPPL. 1, 2012, Pages

  Luft, Friedrich C ^a   Dechend, Ralf ^a   Müller, Dominik N ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Activating autoantibodies; angiotensin; hypertension; immunity; infl ammation; T cells; target organ damage

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II;

ADAPTIVE IMMUNITY; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CELL INFILTRATION; COMPLEMENT SYSTEM; HUMORAL IMMUNITY; HYPERTENSION; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BALANCE;

ADAPTIVE IMMUNITY; ANGIOTENSIN II; ANIMALS; AUTOIMMUNITY; BLOOD VESSELS; BRAIN; CARDIOVASCULAR DISEASES; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; KIDNEY; LYMPHOCYTES; MYOCARDIUM; NF-KAPPA B; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84862521075     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.653396     Document Type: Review

References (24)

1. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dämmrich J, et al. Early interstitial changes in hypertension-induced renal injury. Hypertension. 1993;22:754-65. (Pubitemid 23326223)
2. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera-Acosta J, et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol. 2002;282: F191-201. (Pubitemid 34654549)
3. Rodriguez-Iturbe B, Johnson RJ. The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension. Hypertens Res. 2010;33:975-80.
4. Rodríguez-Iturbe B, Franco M, Tapia E, Quiroz Y, Johnson RJ. Renal inflammation, autoimmunity and saltsensitive hypertension. Clin Exp Pharmacol Physiol. 2012;39: 96-103.
5. Luft FC, Mervaala E, Müller DN, Gross V, Schmidt F, Park JK, et al. Hypertension-induced end-organ damage: A new transgenic approach to an old problem. Hypertension. 1999;33:212-8. (Pubitemid 29065662)
6. Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, et al. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol. 2002;161:1679-93. (Pubitemid 35265527)
7. Muller DN, Mullally A, Dechend R, Park JK, Fiebeler A, Pilz B, et al. Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension. 2002;40:840-6. (Pubitemid 35434904)
8. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, et al. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000;35:193-201. (Pubitemid 30054172)
9. Henke N, Schmidt-Ullrich R, Dechend R, Park JK, Qadri F, Wellner M, et al. Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ Res. 2007;101:268-76. (Pubitemid 47344076)
10. Shagdarsuren E, Wellner M, Braesen JH, Park JK, Fiebeler A, Henke N, et al. Complement activation in angiotensin II-induced organ damage. Circ Res. 2005;97:716-24. (Pubitemid 41416341)
11. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449-60. (Pubitemid 47529329)
12. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, et al. Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation. 2010;122:2529-37.
13. Gratze P, Dechend R, Stocker C, Park JK, Feldt S, Shagdarsuren E, et al. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation. 2008;117:2645-56.
14. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-57. (Pubitemid 16136806)
15. Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2009:418-28.
16. Luft FC. Neural regulation of the immune system modulates hypertension-induced target-organ damage. J Am Soc Hypertens. 2012;6:23-6.
17. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest. 2007;117:1119-27. (Pubitemid 46718396)
18. Yang XF, Fang P, Meng S, Jan M, Xiong X, Yin Y, et al. The FOX transcription factors regulate vascular pathology, diabetes and Tregs. Front Biosci. 2009;1:420-36.
19. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010;11:7-13.
20. Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation. 2009;119:2904-12.
21. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15:545-52.
22. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382-7. (Pubitemid 30329128)
23. Wenzel K, Rajakumar A, Haase H, Geusens N, Hubner N, Schulz H, et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58:77-84.
24. Riemekasten G, Philippe A, Näther M, Slowinski T, Müller DN, Heidecke H, et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis. 2011;70:530-6.